Market Cap 112.82B
Revenue (ttm) 86.01B
Net Income (ttm) 641.00M
EPS (ttm) N/A
PE Ratio 18.30
Forward PE 15.96
Profit Margin 0.75%
Debt to Equity Ratio 1.59
Volume 9,823,671
Avg Vol 4,160,680
Day's Range N/A - N/A
Shares Out 2.48B
Stochastic %K 55%
Beta 1.58
Analysts Strong Sell
Price Target $52.45

Company Profile

Brookfield Corporation is a multi-asset manager focused on real estate, credit, renewable power and transition, infrastructure, venture capital, and private equity including growth capital and emerging growth investments. It manages a range of public and private investment products and services for institutional and retail clients. It typically makes investments in sizeable, premier assets across geographies and asset classes. It invests both its own capital as well as capital from other investo...

Industry: Asset Management
Sector: Financial Services
Phone: 416 363 9491
Fax: 416 363 2856
Address:
Brookfield Place, 181 Bay Street Suite 110 Bay Wellington Tower, Toronto, Canada
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 26 at 7:09 PM
$BN RSI: 38.84, MACD: 0.1454 Vol: 0.89, MA20: 47.09, MA50: 46.16 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PickAlpha
PickAlpha Jan. 22 at 9:49 PM
PickAlpha Midday — Oaktree and Anchorage reportedly built positions in First Brands’ $1.1B DIP loan as the company warns it may run out of cash by month-end without additional financing. The DIP is trading at distressed levels, signaling markets are pricing in a near-inevitable new-money injection that could sit even higher in the capital stack. A key sticking point is ballooning advisory fees, which creditors see as eroding recoveries. Tickers: $BN, $ARES, $HYG Here’s what matters: Our view is this is a classic “new-money controls the restructuring” setup — when the DIP itself trades distressed and liquidity is days/weeks away, negotiations shift from valuation to priority and covenants. If fresh super-senior money gets approved, existing DIP holders can benefit (better control + repayment priority). If talks stall, the path quickly becomes asset sales/shutdown risk, which usually hits recoveries across the stack and widens risk premia in lower-quality credit.
0 · Reply
TheMarketsTheTarget
TheMarketsTheTarget Jan. 20 at 5:19 PM
$BN Gap down and still falling.
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 9 at 11:29 AM
$BN Share Price: $47.23 Contract Selected: Jul 17, 2026 $45 Calls Buy Zone: $4.44 – $5.48 Target Zone: $8.33 – $10.18 Potential Upside: 77% ROI Time to Expiration: 188 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
JB_Research
JB_Research Jan. 8 at 9:52 AM
$BN "Brookfield is positioning itself as a new type of cloud infrastructure provider, leveraging its renewable energy, real estate, and infrastructure assets to deliver predictable, high-capacity computing power and meet increasing AI workload demand." -->what's against?? https://erp.today/brookfield-launches-radiant-to-provide-ai-infrastructure-for-enterprises/
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Jan. 1 at 5:51 PM
$BN Massive volume spike with over 3.5x average volume at 6.4M shares traded. Price had a significant drop from $48.49 to $29.79. Recent price action shows a decrease in volume compared to the spike, indicating potential cooling off. Waiting for a lower H% before considering entry.
0 · Reply
RinaGuerrera510
RinaGuerrera510 Dec. 31 at 5:31 PM
$BN $HOOD $MELI $MCK $CVS Very compelling
0 · Reply
Shik79
Shik79 Dec. 29 at 8:57 PM
$IFRX I dunno about all this depression here. To me: good time to double down now, until news related to PG unblinding. Zooming out I see: This stock is dirt cheap. BP needs: Human proof of biology Clean pharmacokinetics Multi indication signals Acceptable safety Clear path to P2b All that is given. BP sees: C5aR antagonist, oral -> rare $$BN indications Unmet need in HS &CSU Validated mechanism Biology de-risked but early -> discount Small corp -> easy to transact No poison pill Small market cap Validated ("best in class") but not priced. BP naturally has little interest in driving prices prematurely. Mcap ≠ fair enterprise value What's negotiated behind doors (future control) is driving EV. Yeah, this board is looking for short term symptoms: cash clarity, partner, catalyst. But that's result of behind doors stuff.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 29 at 10:38 AM
$BN RSI: 50.73, MACD: 0.1568 Vol: 0.78, MA20: 46.12, MA50: 45.62 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
LALITSETH
LALITSETH Dec. 27 at 4:35 PM
$BN 59011.35. Weak below 59106.Trgs 58300-271 /57950-791. Spot.
0 · Reply
Latest News on BN
Brookfield: A Future $100 Stock Hiding In Plain Sight

Jan 15, 2026, 8:18 AM EST - 19 days ago

Brookfield: A Future $100 Stock Hiding In Plain Sight


My Dividend Growth Income - December 2025 Update

Jan 6, 2026, 8:19 AM EST - 4 weeks ago

My Dividend Growth Income - December 2025 Update

ADI AMZN AVGO BAM BIP BOC CARR


Brookfield Asset Management: Offers Good Growth Potential

Dec 31, 2025, 2:38 AM EST - 4 weeks ago

Brookfield Asset Management: Offers Good Growth Potential

BAM


Brookfield: The Staggering Growth Of Asset Management

Dec 15, 2025, 1:10 PM EST - 7 weeks ago

Brookfield: The Staggering Growth Of Asset Management


Families Unite to Rebuild Their Homes Lost in Fires

Dec 5, 2025, 10:00 AM EST - 2 months ago

Families Unite to Rebuild Their Homes Lost in Fires


3 REITs That Big Money Might Snap Up Soon

Dec 4, 2025, 8:50 AM EST - 2 months ago

3 REITs That Big Money Might Snap Up Soon

BAM BX CIO CSR FPI PLYM REXR


Brookfield to Acquire Fosber

Dec 1, 2025, 6:45 AM EST - 2 months ago

Brookfield to Acquire Fosber

BAM BBU


Brookfield Completes C$250 Million Preferred Share Issue

Nov 26, 2025, 7:54 AM EST - 2 months ago

Brookfield Completes C$250 Million Preferred Share Issue


OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 26 at 7:09 PM
$BN RSI: 38.84, MACD: 0.1454 Vol: 0.89, MA20: 47.09, MA50: 46.16 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PickAlpha
PickAlpha Jan. 22 at 9:49 PM
PickAlpha Midday — Oaktree and Anchorage reportedly built positions in First Brands’ $1.1B DIP loan as the company warns it may run out of cash by month-end without additional financing. The DIP is trading at distressed levels, signaling markets are pricing in a near-inevitable new-money injection that could sit even higher in the capital stack. A key sticking point is ballooning advisory fees, which creditors see as eroding recoveries. Tickers: $BN, $ARES, $HYG Here’s what matters: Our view is this is a classic “new-money controls the restructuring” setup — when the DIP itself trades distressed and liquidity is days/weeks away, negotiations shift from valuation to priority and covenants. If fresh super-senior money gets approved, existing DIP holders can benefit (better control + repayment priority). If talks stall, the path quickly becomes asset sales/shutdown risk, which usually hits recoveries across the stack and widens risk premia in lower-quality credit.
0 · Reply
TheMarketsTheTarget
TheMarketsTheTarget Jan. 20 at 5:19 PM
$BN Gap down and still falling.
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 9 at 11:29 AM
$BN Share Price: $47.23 Contract Selected: Jul 17, 2026 $45 Calls Buy Zone: $4.44 – $5.48 Target Zone: $8.33 – $10.18 Potential Upside: 77% ROI Time to Expiration: 188 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
JB_Research
JB_Research Jan. 8 at 9:52 AM
$BN "Brookfield is positioning itself as a new type of cloud infrastructure provider, leveraging its renewable energy, real estate, and infrastructure assets to deliver predictable, high-capacity computing power and meet increasing AI workload demand." -->what's against?? https://erp.today/brookfield-launches-radiant-to-provide-ai-infrastructure-for-enterprises/
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Jan. 1 at 5:51 PM
$BN Massive volume spike with over 3.5x average volume at 6.4M shares traded. Price had a significant drop from $48.49 to $29.79. Recent price action shows a decrease in volume compared to the spike, indicating potential cooling off. Waiting for a lower H% before considering entry.
0 · Reply
RinaGuerrera510
RinaGuerrera510 Dec. 31 at 5:31 PM
$BN $HOOD $MELI $MCK $CVS Very compelling
0 · Reply
Shik79
Shik79 Dec. 29 at 8:57 PM
$IFRX I dunno about all this depression here. To me: good time to double down now, until news related to PG unblinding. Zooming out I see: This stock is dirt cheap. BP needs: Human proof of biology Clean pharmacokinetics Multi indication signals Acceptable safety Clear path to P2b All that is given. BP sees: C5aR antagonist, oral -> rare $$BN indications Unmet need in HS &CSU Validated mechanism Biology de-risked but early -> discount Small corp -> easy to transact No poison pill Small market cap Validated ("best in class") but not priced. BP naturally has little interest in driving prices prematurely. Mcap ≠ fair enterprise value What's negotiated behind doors (future control) is driving EV. Yeah, this board is looking for short term symptoms: cash clarity, partner, catalyst. But that's result of behind doors stuff.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 29 at 10:38 AM
$BN RSI: 50.73, MACD: 0.1568 Vol: 0.78, MA20: 46.12, MA50: 45.62 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
LALITSETH
LALITSETH Dec. 27 at 4:35 PM
$BN 59011.35. Weak below 59106.Trgs 58300-271 /57950-791. Spot.
0 · Reply
GammaGainV3
GammaGainV3 Dec. 24 at 4:08 PM
$BN Capital markets will reward the credibility of guidance translating into repeatable cash generation, with outcomes shaped by timing and discipline. Uncertainty remains until results confirm narrative.
0 · Reply
LALITSETH
LALITSETH Dec. 17 at 3:39 AM
$BN TRGS
0 · Reply
topstockalerts
topstockalerts Dec. 16 at 8:56 PM
GE Vernova is developing fuel cell technology aimed at commercial deployment within one to two years, with industrial-scale manufacturing expected in two to three years. The company’s fuel cells use “thermal spray technology,” allowing cost-competitive production at larger physical scale. GE Vernova’s move targets AI data centers, a fast-growing market for off-grid or backup power, where fuel cells are seen as cleaner and more efficient alternatives to natural gas turbines. Bloom Energy, the current market leader, has seen its stock surge 260% this year but fell 20% recently amid news of GE Vernova entering the space. Analysts view the new business as a promising opportunity for GE Vernova, leveraging existing R&D to reduce costs, while its entrance validates and intensifies competition in the fuel cell sector. $GE $GEV $BE $ORCL $BN
1 · Reply
TheLaw17
TheLaw17 Dec. 11 at 11:00 PM
$BN Carney's scam company. Trash stock.
0 · Reply
briefingcom
briefingcom Dec. 9 at 1:21 PM
$BN: Brookfield Corp. and Qai form $20 billion strategic investment partnership for AI infrastructure https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20251209060741BN&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
0 · Reply
ValueInvestor007
ValueInvestor007 Dec. 6 at 8:00 AM
$RITM update from Rithm Capital CEO Michael Nierenberg looking for sovereign fund investors in Abu Dhabi while outlining the firm’s playbook - from aggressive acquisitions like Crestline and Paramount to scaling its asset-management business… Undervalued company with much upside coming ! Very bullish about this one… $APO $KKR $ARES $BN https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.cnbc.com%2Fvideo%2F2025%2F12%2F04%2Fhow-this-reit-is-deploying-its-53-billion-capital.html&data=05%7C02%7Cjeroen.nijs%40agthia.com%7Cca82cf16bc514dc8899008de34904320%7C246a161b2a0442b7bf8ffdaa3214caf7%7C0%7C0%7C639005991384742650%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=bYNN3GXK4j%2BmtvODF8zHvhKrtiQq1P7RacJIRtXj3QA%3D&reserved=0
1 · Reply
Garfeild
Garfeild Dec. 5 at 8:51 PM
$BN I can’t stand Canada. Might as well profit from it
0 · Reply
BillionerOfKing
BillionerOfKing Nov. 29 at 12:55 AM
$BN Current Stock Price: $47.00 Contracts to trade: $45 BN Dec 19 2025 Call Entry: $2.40 Exit: $4.70 ROI: 96% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
FRAGMENTS
FRAGMENTS Nov. 28 at 7:47 PM
0 · Reply
FRAGMENTS
FRAGMENTS Nov. 27 at 8:33 PM
$SPY Blackstone isn’t “just” a PE fund. It’s the plumbing of modern finance — warehouses, student housing, data centers, insurance capital, and slices of household debt. In this CEO Series, we look at how Stephen Schwarzman and Jonathan Gray turned fees + float into a compounding machine by using cycles (not stories) and building a firm that sells capital, certainty, and solutions — not just deals. — FRAGMENTS, CEO Series — Blackstone HERE: https://cundilldeepvalue.substack.com/p/ceo-series-blackstone-stephen-schwarzman $BN $BAM $TSLA $NVDA $AAPL
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 27 at 5:05 PM
$BN Share Price: $46.59 Contract Selected: Jul 17, 2026 $45 Calls Buy Zone: $4.59 – $5.67 Target Zone: $7.89 – $9.64 Potential Upside: 62% ROI Time to Expiration: 231 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply